谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Biomarkers Associated with Outcomes from KEYLYNK-010: Pembrolizumab (pembro) Plus Olaparib (ola) Versus Next-Generation Hormonal Agent (NHA) in Previously Treated Metastatic Castration-Resistant Prostate Cancer (Mcrpc).

Evan Y. Yu,Se Hoon Park,Jeffrey C. Goh,Sang Joon Shin,Niven Mehra,Raymond S. McDermott,Peter C. C. Fong,Richard Greil,Juan Pablo Sade,Yi-Hsiu Huang, Gero Kramer,Hiroyoshi Suzuki,Christian Heinrich Poehlein,Ping Qiu,E. J. Dettman, April Wang,Cai Chen,Razvan Cristescu,Matthew J. Marton,Emmanuel S. Antonarakis

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要